Get the Stockscreener App
0.668
3.61%
0.0233
Envoy Medical Inc stock is traded at $0.668, with a volume of 41,292.
It is up +3.61% in the last 24 hours and down -5.93% over the past month.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
See More
Previous Close:
$0.6447
Open:
$0.659
24h Volume:
41,292
Relative Volume:
0.63
Market Cap:
$51.70M
Revenue:
$234.00K
Net Income/Loss:
$-23.11M
P/E Ratio:
-0.649
EPS:
-1.0292
Net Cash Flow:
$-20.71M
1W Performance:
+1.55%
1M Performance:
-5.93%
6M Performance:
-4.79%
1Y Performance:
-21.41%
1-Day Range:
$0.6442
$0.6693
1-Week Range:
$0.61
$0.6699
52-Week Range:
$0.3625
$0.9539
Envoy Medical Inc Stock (COCH) Company Profile
Name
Envoy Medical Inc
Sector
Industry
Phone
651-361-8000
Address
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Compare COCH vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COCH
Envoy Medical Inc
|
0.668 | 51.70M | 234.00K | -23.11M | -20.71M | -1.0292 |
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-06-26 | Initiated | Lake Street | Buy |
| Mar-31-26 | Initiated | H.C. Wainwright | Buy |
| Jun-24-24 | Initiated | Ascendiant Capital Markets | Buy |
Envoy Medical Inc Stock (COCH) Latest News
A surgeon joining P3 Health Partners gets an option to buy 110,000 shares. - Stock Titan
Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant - www.marketscreener.com
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio - TMX Newsfile
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio - Yahoo Finance
A hearing-device maker adds two patents, bringing its global total to 97 - Stock Titan
Alta Partners reports 2.1M Envoy Medical (COCH) shares - stocktitan.net
Enterprise value to EBIT forward of Envoy Medical, Inc. – NASDAQ:COCHW - TradingView
COCH News | ENVOY MEDICAL INC (NASDAQ:COCH) - ChartMill
Price to earnings forward of Envoy Medical, Inc. – NASDAQ:COCHW - TradingView
Envoy Medical CEO to present fully implanted he... - Pluang
Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th - Yahoo Finance
Envoy Medical CEO to Present at H.C. Wainwright 28th Annual Global Investment Conference in September 2026 - kalkine.ca
Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th - TMX Newsfile
Envoy Medical Inc. (NASDAQ: COCH) Share Price, COCH Stock News, COCH Share Price & Updates - kalkine.ca
Envoy Medical (NASDAQ: COCH) weighs 1‑for‑25 reverse split to avoid delisting - Stock Titan
Envoy Medical Inc (COCH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Envoy Medical names Robert Potashnick Chief Accounting Officer and VP of Finance - TradingView
Envoy Medical (COCH) awards 250K options to Potashnick - stocktitan.net
Are Medical Stocks Lagging Compugen (CGEN) This Year? - Yahoo Finance
HC Wainwright Cuts Envoy Medical (NASDAQ:COCH) Price Target to $2.00 - MarketBeat
H.C. Wainwright cuts Envoy Medical stock price target on share count - Investing.com Canada
H.C. Wainwright cuts Envoy Medical stock price target on share count - Investing.com UK
COCH Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
Envoy (COCH) Earnings Report: Profit Per Share Surpasses Its Benchmark in the Current Update; Price Move - vinanet.vn
Envoy (COCH) Q1 2026 Earnings: The Bottom-Line Figure Beats Its Comparison for the Current Session - vinanet.vn
Envoy (COCHW) Momentum: Trades in a Narrow Directional Range at $0.05 at the Close - vinanet.vn
Envoy Medical Warrant (COCHW) Holds at $0.05 as Flat Trading PersistsBullish Percent Index - Vinanet
Envoy Medical Warrant (COCHW) Holds at $0.05 as Flat Trading PersistsVolume Breakout Ideas - dars.gov.et
Price to sales forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Price to earnings forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
New to The Street Its The Platformsinvestor distribution. - ACCESS Newswire
New to The Street Airs This Weekend Across Bloomberg Television U.S., Latin America and MENA - Caledonian Record
The Beat: Target names AI chief, Niron gets White House backing, Envoy chases cochlear market - The Business Journals
Envoy Medical’s Limited Disclosures Put Spotlight on 10-K Risk Factors for Investors - TipRanks
Envoy Medical earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Envoy Medical earnings beat, revenue fell short of estimates - Investing.com
Envoy Medical (NASDAQ: COCH) raises cash, advances fully implanted cochlear implant - Stock Titan
Envoy Medical Releases Q2 2026 Financial Results - AlphaStreet
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Envoy Medical (NASDAQ:COCH) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Envoy Medical Q2 Results: EPS beats estimate, sales miss - scanx.trade
Envoy Medical, Inc. Q2 2026: Revenue $51K, Net loss $5982K — 10-Q Summary - TradingView
Envoy Medical (NASDAQ: COCH) burns cash on Acclaim implant trial after $28M raise - Stock Titan
Price to book forward of Envoy Medical, Inc. – NASDAQ:COCHW - TradingView
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones - newsfilecorp.com
Envoy Medical (COCH) Reports Q2 2026 Results, Submits First FDA PMA Module and Posts Strong Acclaim® Cochlear Implant Clinical Data - kalkine.ca
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones - Yahoo Finance
Envoy Medical Inc (COCH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Envoy Medical (COCH) Holds Near $0.68 as Hearing Implant Developer Digests Post-Listing VolatilityEntry Point Alerts - vinanet.vn
New to The Street TV Announces Broadcast of Show No. 765 Tonight on Bloomberg Television at 6:30 PM ET Featuring Envoy Medical, Graphene Manufacturing Group, Rhino Bitcoin, and Big Sky Industrial - Newswire.com
Envoy Medical Inc Stock (COCH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Envoy Medical Inc Stock (COCH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Potashnick Robert | Interim CFO |
Feb 12 '26 |
Buy |
0.40 |
212,500 |
85,000 |
212,500 |
| Kantor Susan | Director |
Feb 12 '26 |
Buy |
0.40 |
96,150 |
38,460 |
174,037 |
| BRYNELSEN CHARLES | Director |
Feb 12 '26 |
Buy |
0.40 |
1,000,000 |
400,000 |
1,050,000 |
| Lucas Brent T. | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.40 |
62,500 |
25,000 |
297,090 |
| TAYLOR GLEN A | 10% Owner |
Feb 12 '26 |
Buy |
0.40 |
18,750,000 |
7,500,000 |
21,703,607 |
1.95%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):